
BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points
Published on December 21, 2024
that it has entered into definitive agreements with certain institutional investors for the issuance and sale of 9,679,158 shares of its
